DOPAMINE AND HUNTINGTON'S DISEASE: ASSESSMENT USING THE KAINIC ACID MODEL
Authors:
- Robert SchwarczRSRobert Schwarcz
- Kjell FuxeKFKjell Fuxe
- Tomas HökfeltTHTomas Hökfelt
- Kurt AnderssonKAKurt Andersson
- Joseph T. CoyleJCJoseph T. Coyle
- 1 January 1979
- book chapter
- Published by Elsevier
- p. 115-126
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dopamine receptors localised on cerebral cortical afferents to rat corpus striatumNature, 1978
- Striatal lesions with kainic acid: neurochemical characteristicsBrain Research, 1977
- Evidence for a decrease in substance P content of substantia nigra in Huntington's choreaBrain Research, 1977
- Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acidsNature, 1976
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976
- HUNTINGTON'S CHOREABrain, 1974
- CATECHOLAMINES IN FETAL AND NEWBORN RAT BRAINJournal of Neurochemistry, 1973
- Huntington's ChoreaNew England Journal of Medicine, 1973
- A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brainNaunyn-Schmiedeberg's Archives of Pharmacology, 1972
- Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylaseNaunyn-Schmiedeberg's Archives of Pharmacology, 1972